Semaglutide-Associated Severe Gastrointestinal Intolerance and Hepatic Granulomas: A Case Report
Journal of Diabesity · 12.09.2025 · 1 (1)
DOI: 10.66381/jod.2025.003 ↗Kurz gefasst
Fallbericht in der Zeitschrift Journal of Diabesity, online erschienen am 12.09.2025. Verfasst von Aqsa Khan und 3 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Semaglutide (commonly known as Ozempic, Rybelsus, and Wegovy) is a glucagon-like peptide-1 (GLP-1) receptor agonist. It is increasingly prescribed for diabetes and weight loss. While gastrointestinal side effects are well recognized, hepatic granulomas associated with its use have not been reported in the literature. Case Presentation: A 36-year-old woman without comorbidities developed persistent nausea, early satiety, anorexia, diarrhea, and 5 kg weight loss within 4 weeks of starting semaglutide 0.25 mg weekly. Ultrasound imaging revealed multiple hepatic granulomas. Laboratory, infectious, and autoimmune evaluations were unremarkable. Following drug discontinuation, her symptoms resolved, and repeat imaging showed resolution of granulomas, eliminating the need for biopsy.
Discussion
This case highlights an atypical presentation of severe gastrointestinal intolerance and hepatic granulomas at a very low dose of semaglutide. The temporal association and resolution after withdrawal suggest a drug-induced hypersensitivity reaction or an immune dysfunction associated with its use.
Conclusion
Clinicians should remain alert for unusual adverse effects of semaglutide, even at initiation doses. Imaging and close follow-up are essential in cases with unexplained gastrointestinal symptoms and hepatic abnormalities. Keywords: Semaglutide, GLP-1 receptor agonist, hepatic granulomas, gastrointestinal adverse effects
Zitieren
APA
Khan, A., Rashid, B., Fareedullah, & Sibghatullah (2025). Semaglutide-Associated Severe Gastrointestinal Intolerance and Hepatic Granulomas: A Case Report. Journal of Diabesity, 1(1). https://doi.org/10.66381/jod.2025.003
Vancouver
Khan A, Rashid B, Fareedullah, Sibghatullah. Semaglutide-Associated Severe Gastrointestinal Intolerance and Hepatic Granulomas: A Case Report. Journal of Diabesity. 2025;1(1). doi:10.66381/jod.2025.003
BibTeX
@article{Khan2025,
author = {Khan, Aqsa and Rashid, Badeeya and Fareedullah and Sibghatullah},
title = {Semaglutide-Associated Severe Gastrointestinal Intolerance and Hepatic Granulomas: A Case Report},
journal = {Journal of Diabesity},
year = {2025},
volume = {1},
number = {1},
doi = {10.66381/jod.2025.003}
}
EUVIMED